Ray Dalio
SYNH

Ray Dalio’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Ray Dalio’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-98,086
Closed -$3.6M – 930
2022
Q4 		$3.6M Buy
+98,086
New +$3.88M 0.02% 425

Other funds holding SYNH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Ray Dalio's SYNH Position: Q1 2023 in Review

Ray Dalio sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 98,086 shares — an estimated $3.6M sold.

Ray Dalio first reported a position in SYNH in Q4 2022 and held it in 1 quarter. The position peaked at $3.6M in Q4 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Ray Dalio reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ray Dalio sold 98,086 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $3.6M.
  • Ray Dalio first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Ray Dalio's Syneos Health, Inc. Class A Common Stock position peaked at $3.6M in Q4 2022.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.